Effective treatment of refractory sympathetic ophthalmia with glaucoma using adalimumab
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2019/06/01
-
Indian UGC (journal)
-
Refrences19
-
Citations11
-
Tomona Hiyama
-
Yosuke Harada
-
Yoshiaki Kiuchi ORCID (unauthenticated)
Cite
Hiyama, Tomona, et al. “Effective Treatment of Refractory Sympathetic Ophthalmia With Glaucoma Using Adalimumab”. American Journal of Ophthalmology Case Reports, vol. 14, 2019, pp. 1-4, https://doi.org/10.1016/j.ajoc.2019.01.009.
Hiyama, T., Harada, Y., & Kiuchi, Y. (2019). Effective treatment of refractory sympathetic ophthalmia with glaucoma using adalimumab. American Journal of Ophthalmology Case Reports, 14, 1-4. https://doi.org/10.1016/j.ajoc.2019.01.009
Hiyama, Tomona, Yosuke Harada, and Yoshiaki Kiuchi. “Effective Treatment of Refractory Sympathetic Ophthalmia With Glaucoma Using Adalimumab”. American Journal of Ophthalmology Case Reports 14 (2019): 1-4. https://doi.org/10.1016/j.ajoc.2019.01.009.
Hiyama T, Harada Y, Kiuchi Y. Effective treatment of refractory sympathetic ophthalmia with glaucoma using adalimumab. American Journal of Ophthalmology Case Reports. 2019;14:1-4.
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III | Ophthalmology |
| 116 | 2018 |
| Adalimumab for Pediatric Sympathetic Ophthalmia | JAMA Ophthalmology |
| 11 | 2014 |
| Sympathetic ophthalmia: to the twenty-first century and beyond | Journal of Ophthalmic Inflammation and Infection |
| 68 | 2013 |
| Successful Treatment of Refractory Sympathetic Ophthalmia in a Child With Infliximab | Archives of Ophthalmology | 26 | 2011 | |
| Vogt–Koyanagi–Harada disease diagnostic criteria | International Ophthalmology |
| 56 | 2007 |
Refrences Analysis
| Category | Category Repetition |
|---|---|
| Medicine: Medicine (General) | 11 |
| Medicine: Ophthalmology | 7 |
| Medicine | 6 |
| Medicine: Internal medicine | 1 |
The category
Medicine: Medicine (General) 11
is the most frequently represented among the references in this article. It primarily includes studies from Archives of Ophthalmology and Ophthalmology. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Sympathetic Ophthalmia: Demographic Characteristics, Clinical Findings, and Treatment Results | Turkish Journal of Ophthalmology |
| 2023 | |
| Incidence of Sympathetic Ophthalmia after Inciting Events | Ophthalmology |
| 6 | 2022 |
| Sympathetic Ophthalmia - An Overview | Ocular Immunology and Inflammation |
| 3 | 2022 |
Clinical and imaging features of sympathetic ophthalmia and efficacy of the current therapy | Acta Ophthalmologica |
| 2 | 2022 |
Recent advances in diagnosis and management of sympathetic ophthalmia | Current Opinion in Ophthalmology |
| 2021 |
Citations Analysis
| Category | Category Repetition |
|---|---|
| Medicine: Ophthalmology | 9 |
| Medicine: Medicine (General) | 6 |
| Medicine | 1 |
The category
Medicine: Ophthalmology 9
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Long-term Observation of Patients with Sympathetic Ophthalmia from a Diagnostic and Therapeutic Perspective. Overview of Literature and was published in 2019. The most recent citation comes from a 2023 study titled Sympathetic Ophthalmia: Demographic Characteristics, Clinical Findings, and Treatment Results. This article reached its peak citation in 2022, with 3 citations. It has been cited in 11 different journals, 18% of which are open access. Among related journals, the Turkish Journal of Ophthalmology cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.